In 2010, the US public and private sectors invested $140.5 billion in 2010 on research to find new ways to treat, cure and prevent disease and disability, according to non-profit public education and advocacy alliance Research!America's latest annual estimate.
Health research spending accounted for only 5.5% of the $2,600 billion the USA spent on health care in 2010. Health research as a percentage of health care spending has hovered around 5.5% since 2005, remaining essentially stagnant.
Investment in health research experienced only a 1% growth over 2009 levels, from $139 billion in 2009 to $140.5 billion in 2010. This small increase was not enough to keep pace with the rise in the cost of conducting health research.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze